3531
|
GSK484 hydrochloride
|
Highly potent, selective, and reversible PAD4 inhibitor |
€150.00 |
1625
|
GSK579289A
|
PLK1 Inhibitor |
€110.00 |
2970
|
GSK626616
|
Potent, orally bioavailable inhibitor of DYRK3 |
€120.00 |
2617
|
GSK837149
|
Selective inhibitor of human fatty acid synthase (FAS) |
€120.00 |
3852
|
GSK923295
|
Allosteric inhibitor of centromere-associated protein E (CENP-E) |
Inquire |
2860
|
GTS 21 dihydrochloride
|
Selective α7 nicotinic acetylcholine receptor (nAChR) partial agonist |
€90.00 |
3383
|
Guanfacine hydrochloride
|
Selective α2 adrenoceptor agonist |
€50.00 |
2571
|
GW 2580
|
Orally bioavailable inhibitor of cFMS kinase and CSF1R |
€75.00 |
3059
|
GW 284543 hydrochloride
|
Selective MEK5 inhibitor |
€95.00 |
2364
|
GW 311616A
|
Potent, selective and orally active human neutrophil elastase (HNE) inhibitor |
€120.00 |
1266
|
GW 3965 hydrochloride
|
Liver X receptor agonist |
€95.00 |
1974
|
GW 406381
|
COX-2 inhibitor |
€120.00 |
1251
|
GW 441756
|
TrkA inhibitor |
€75.00 |
1984
|
GW 5074
|
Brain-permeable inhibitor of c-Raf (in vitro) with activating effects in vivo |
€85.00 |
1237
|
GW 7647
|
PPARα agonist |
€95.00 |
1832
|
GW 788388
|
TGF-βR 1 inhibitor |
€50.00 |
1967
|
GW 791343 hydrochloride
|
P2X7 receptor antagonist and allosteric modulator |
Inquire |
1569
|
GW 803430
|
MCH1 antagonist |
€90.00 |
1925
|
GW 842166X
|
Cannabinoid CB2 receptor agonist |
€110.00 |
1131
|
GW 843682X
|
PLK1 and PLK3 inhibitor |
€85.00 |
2013
|
GW 9508
|
GPR40 receptor agonist (FFA1) |
€85.00 |
2262
|
GW 9662
|
Selective PPARγ antagonist |
€60.00 |
3289
|
GW4869 trifluoroacetate
|
Noncompetitive, neutral, magnesium-dependent SMase inhibitor |
€65.00 |
1374
|
GYKI 53655
|
AMPA antagonist |
€130.00 |